In recent years, several beneficial cell samples and microbial strains have been discovered, engineered, and studied, resulting in scientific discoveries and other technological breakthroughs such as vaccines and medicines benefitting communities all around the world. However, several medical products tend to require very low temperatures for storage, making Ultra-Low Freezers increasingly important to maintain their viability.
Catalent swallows VMIC Ltd
Latest NewsCatalent has acquired a biologics manufacturing site from VMIC Ltd that is still under construction.
AXA launches €440 m private equity healthcare strategy
Latest NewsAXA IM Alts, has launched a Global Health Strategy following a €18m cornerstone commitment from AXA Group, as it builds on its existing offering in the sector.
Creating a safe ultra-low cold storage environment
BackgroundIn recent years, several beneficial cell samples and microbial strains have been discovered, engineered, and studied, resulting in scientific discoveries and other technological breakthroughs such as vaccines and medicines benefitting communities all around the world. However, several medical products tend to require very low temperatures for storage, making Ultra-Low Freezers increasingly important to maintain their viability.
Bayer Leaps to invests €1.3bn externally
Latest NewsGerman Bayer AG has announced it will channel at least €1.3b by the end of 2024 in its investment arm ‘Leaps by Bayer’.
IZB start-up AMSilk GmbH
Sponsored PublicationsBuilding a sustainable future this is what drives us. We are passionate about making smart biotech materials part of everyday life. We believe nature offers better alternatives to existing materials with biofabricated technologies previously unimaginable – enabling our customers to make a true change.
Avantium closes financing for FDCA plant
Latest NewsAvantium NV has reached financial close for the construction of a 5,000 ton FDCA plant, one of the two monomers needed to make fossil-free, recyclable PEF.
Anders Tegnell joins WHO
AppointmentsThe Swedish chief epidemiologist Anders Tegnell plans to move to the World Health Organisation (WHO) in Geneva.
Novo Holdings co-leads €40m Qure.ai financing
Latest NewsDeep learning medical imaging specialist Qure.ai raises $40m from healthcare investors Novo Holdings and HealthQuad
After the setback, what's next for biotech stocks?
OpinionWhile the Nasdaq Biotechnology index saw a huge uplift during the pandemic (+ 77% since March 2020 until reaching a peak in August 2021), it lost 27% during the last six months vs a 11%/4% decline for the Nasdaq Composite and the S&P 500, respectively
Sanofi and IGM Biosciences Inc. in $6.15bn deal
Latest NewsSanofi and IGM Biosciences have entered into a broad antibody discovery collaboration that could bring in IGM $6bn if all milestones are met.